These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7243230)

  • 21. Recent developments in dry eye management.
    Lemp MA
    Ophthalmology; 1987 Oct; 94(10):1299-304. PubMed ID: 3317182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of keratoconjunctivitis sicca].
    Klemetti A
    Duodecim; 1983; 99(23-24):1761-4. PubMed ID: 6667636
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of a severe course of keratoconjunctivitis sicca with eledoisin].
    Jaeger W
    Klin Monbl Augenheilkd; 1988 Feb; 192(2):163-6. PubMed ID: 3283426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron Keratoconjunctivitis Sicca Study Group.
    Nelson JD; Gordon JF
    Am J Ophthalmol; 1992 Oct; 114(4):441-7. PubMed ID: 1415455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New approaches to the treatment of keratoconjunctivitis sicca].
    Safonova TN; Gladkova OV; Novikov IA; Boev VI; Fedorov AA
    Vestn Oftalmol; 2017; 133(2):75-81. PubMed ID: 28524144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
    Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tear lactoferrin in keratoconjunctivitis sicca].
    Hu FR; Wang TH; Lin LL; Ko LS
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):422-5. PubMed ID: 2794946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term Supplementation With n-6 and n-3 PUFAs Improves Moderate-to-Severe Keratoconjunctivitis Sicca: A Randomized Double-Blind Clinical Trial.
    Sheppard JD; Singh R; McClellan AJ; Weikert MP; Scoper SV; Joly TJ; Whitley WO; Kakkar E; Pflugfelder SC
    Cornea; 2013 Oct; 32(10):1297-304. PubMed ID: 23884332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantation of the autologous submandibular gland for most severe cases of keratoconjunctivitis sicca.
    Geerling G; Sieg P; Bastian GO; Laqua H
    Ophthalmology; 1998 Feb; 105(2):327-35. PubMed ID: 9479295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of topical human amniotic fluid and human serum in a mouse model of keratoconjunctivitis sicca.
    Quinto GG; Camacho W; Castro-Combs J; Li L; Martins SA; Wittmann P; Campos M; Behrens A
    Cornea; 2012 Apr; 31(4):424-30. PubMed ID: 22290385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term use of hydroxypropyl cellulose ophthalmic insert to relieve symptoms of dry eye in a contact lens wearer: case-based experience.
    Wander AH
    Eye Contact Lens; 2011 Jan; 37(1):39-44. PubMed ID: 21178699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid assay of lactoferrin in keratoconjunctivitis sicca.
    McCollum CJ; Foulks GN; Bodner B; Shepard J; Daniels K; Gross V; Kelly L; Cavanagh HD
    Cornea; 1994 Nov; 13(6):505-8. PubMed ID: 7842709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of pH and osmolarity on the ability of tolerate artificial tears.
    Motolko M; Breslin CW
    Am J Ophthalmol; 1981 Jun; 91(6):781-4. PubMed ID: 7246701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Artificial tears developed by the author in a case of keratoconjunctivitis sicca].
    Andrzejewska W; Stolarska H; Klera C; Kirylowicz K
    Klin Oczna; 1972; 42(3):889-91. PubMed ID: 5030425
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of rebamipide ophthalmic suspension on signs and symptoms of keratoconjunctivitis sicca in Sjögren syndrome patients with or without punctal occlusions.
    Arimoto A; Kitagawa K; Mita N; Takahashi Y; Shibuya E; Sasaki H
    Cornea; 2014 Aug; 33(8):806-11. PubMed ID: 24977983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.
    Pflugfelder SC; Maskin SL; Anderson B; Chodosh J; Holland EJ; De Paiva CS; Bartels SP; Micuda T; Proskin HM; Vogel R
    Am J Ophthalmol; 2004 Sep; 138(3):444-57. PubMed ID: 15364229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Our further experience with bromhexine in keratoconjunctivitis sicca.
    Avisar R; Savir H
    Ann Ophthalmol; 1988 Oct; 20(10):382. PubMed ID: 3207309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model.
    Lekhanont K; Leyngold IM; Suwan-Apichon O; Rangsin R; Chuck RS
    Cornea; 2007 Jan; 26(1):84-9. PubMed ID: 17198019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tear film osmolarity and keratoconjunctivitis sicca.
    Gilbard JP
    CLAO J; 1985; 11(3):243-50. PubMed ID: 4042314
    [No Abstract]   [Full Text] [Related]  

  • 40. Group IIA phospholipase A2 content of tears in patients with keratoconjunctivitis sicca.
    Aho VV; Nevalainen TJ; Saari KM
    Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):521-3. PubMed ID: 12136279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.